Pregabalin in benzodiazepine withdrawal.
Biermann
T
T
Bleich
S
S
Kornhuber
J
J
Hillemacher
T
T
D000328:Adult; D000525:Alprazolam / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D010698:Phobic Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D000069583:Pregabalin; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000523:psychology; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000525:Alprazolam